The use of human challenges get trials is a very different situation, and the decision of whether or not to engage in one is definitely a question where economi

The use of human challenges get trials is a very different situation, and the decision of whether or not to engage in one is definitely a question where economists and ethicists have a lot to contribute, I'm glad you're engaged in the conversation. Its a tough utility/risk-reward/ethics question, where we'd be able to speed up development of immunization approaches by a LOT, but with a virus we still don't fully understand and that keeps surprising us. Definitely a decision that needs cross discipline input and discussion.